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The following procedures are the 3 principal
methods of endovascular repair (EVR) of abdominal
aortic aneurysms (AAA): aorto-aortic bypass graft-
ing, bifurcated bypass grafting, and aorta uni-iliac
grafting. The latter technique has been detailed pre-
viously1 and essentially involves the deployment of a
bypass graft from the proximal neck of the aneurysm
into a common iliac artery. The contralateral com-
mon iliac artery is occluded and, to maintain con-
tralateral pelvic and limb perfusion, a femorofemoral
crossover bypass graft is performed. One anastomo-
sis for the crossover bypass graft is made more diffi-
cult technically by the presence of an angiogram
catheter that passes through the anastomosis and
through the femoral artery to the aorta. This
catheter enables a completion angiogram to be per-
formed. Aorta uni-iliac devices have the potential
disadvantages associated with extra-anatomic bypass
grafts (ie, bypass graft infection, bypass graft occlu-
sion, and false aneurysm formation).2 The aim of
this study was to review the outcomes and the com-
plications attributable to the femorofemoral
crossover bypass graft in patients who have under-
gone aorta uni-iliac EVR of AAA.
METHODS
In a 31⁄2-year period, 136 patients underwent aorta
uni-iliac EVR of AAA and femorofemoral crossover
bypass grafting. The median aneurysm size was 6.3
cm (range, 3.2 to 10.2 cm), and the median follow-
up period was 7 months (range, 0 to 36 months). All
procedures were performed in an operating theater,
with use of skin disinfectant, sterile drapes, iodine
unpregnated skin adhesive covering, and prophylactic
intravenous perioperative antibiotics (cephalosporin-
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Objective: The following procedures are the 3 main methods of endovascular repair
(EVR) of abdominal aortic aneurysms (AAA): aorto-aortic bypass grafting, bifurcated
bypass grafting, and aorta uni-iliac grafts. The latter method has the potential disad-
vantage of requiring an extra anatomic graft (ie, a femorofemoral crossover bypass graft)
to maintain contralateral pelvic and limb perfusion. The aim of this study was to assess
the complications associated with the femorofemoral crossover bypass graft after aorta
uni-iliac EVR of AAA.
Method: A prospective review was conducted of the complications attributable to the
femorofemoral crossover bypass graft in 136 patients who underwent EVR of AAA with
an aorta uni-iliac device.
Results: During a median follow-up of 7 months (range, 0 to 36 months), 4 patients had
superficial wound infections that required antibiotic treatment and 2 patients had
bypass graft infections. Nine hematomas developed: 7 (5%) groin hematomas (6 in
patients with Dacron bypass grafts), 1 scrotal hematoma, and 1 perigraft hematoma.
One bypass graft thrombus developed.
Conclusion: The femorofemoral crossover bypass graft is a safe and a durable component
of EVR of AAA with an aorta uni-iliac device. The results are similar to those with bifur-
cated devices. (J Vasc Surg 1998;28:647-50.)
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based or penicillin-based). Data on complications
from the procedure were collected prospectively. A
wound infection was defined as the presence of ery-
thema more than 5 mm from the wound edge, the
presence of pus in the wound, or wound dehiscence.
Graft infections were confirmed on radioisotope-
labeled white-cell scans if clinically indicated. A
hematoma was defined as the early presence of a
swelling thought to be caused by a collection of blood
and associated with subcutaneous bruising, as
opposed to a seroma, which would occur late, have a
softer swelling, and would be associated with the dis-
charge of a clear sterile fluid from the wound. A
minor complication required conservative treatment,
and a major complication required surgical interven-
tion.
RESULTS
Of the 136 femorofemoral bypass grafts, 109
used Dacron as the conduit and 27 used polytetra-
fluoroethylene (PTFE). The complications associat-
ed with the bypass grafts are shown in Table I. Four
patients had superficial wound infections that
required antibiotic treatment, and 2 patients had
bypass graft infections. Seven (5%) groin hematomas
occurred, 6 in patients with Dacron grafts. One
scrotal hematoma, 1 perigraft hematoma, and 1
femorofemoral bypass graft occlusion were seen. In
the latter case, the patient was first seen in another
hospital with an infected false aneurysm of the
femoral crossover bypass graft. This crossover bypass
graft was removed and replaced with an in situ
gelatin-coated Dacron bypass graft soaked with
rifampicin. However, this bypass graft occluded
because of technical problems. A bypass graft revi-
sion then was performed, and, at follow up 3
months later, the patient was progressing well. The
second infected graft (case 6) was removed and
replaced with a rifampicin-soaked gelatin-coated
superficial axillobifemoral bypass graft that avoided
previous incisions. The common femoral arteri-
otomies were oversewn.
In this series, there were 4 cases of aortic graft
occlusion. One occurred in the perioperative period
and required additional iliac stents to resolve a kink
in the graft. The remaining 3 occurred late at 2
months, 8 months, and 15 months, and all were
treated with axillofemoral bypass grafting.
One death in this series could be related to the
femorofemoral crossover bypass graft. A methicillin-
resistant Staphylococcus aureus infection developed in
the groin wound, which led to an infected anasto-
motic breakdown and hemorrhage. This necessitated
an emergency bypass graft removal and replacement
with a rifampicin-soaked bypass graft. Unfortunately,
the patient died of overwhelming sepsis 2 weeks later.
The median operating time for all patients in this
study was 150 minutes (range, 60 to 480 minutes).
No significant differences were seen in the operating
times of patients who did and patients who did not
develop wound or bypass graft infections. The medi-
an times were 150 minutes (range, 60 to 480 min-
utes) versus 150 minutes (range, 120 to 230 min-
utes), with a P value of .99 (Mann-Whitney U test).
DISCUSSION
Previous reports on femorofemoral bypass grafts
have been related to patients with occlusive arterial
disease. This report is one of the first to report the
outcome of femorofemoral crossover bypass grafts in
patients with aneurysmal disease. This condition is
rarely treated with an extra-anatomical bypass graft,
the possible exception being treatment of an infected
aortic bypass graft. Therefore, it is difficult to com-
pare patency rates and long-term bypass graft infec-
tion rates with those of other studies. The reported
outcomes from the present study are at least as good
as the outcomes reported for patients with occlusive
disease. Patency rates for femorofemoral bypass grafts
vary in the literature. Ng et al3 reported a cumulative
patency rate at 6 years of 92% for femorofemoral
crossover procedures and a low early mortality rate of
1.3%, whereas Lamerton et al4 showed a cumulative
patency rate of 60% at 5 years. In our series, there has
been only 1 femorofemoral bypass graft occlusion to
date, although follow-up has been short. Patency
rates in this group of patients may be higher than in
those with occlusive disease because both the inflow
and the run-off are good.
The high incidence rate of groin hematomas, not
noted previously in other studies of EVR of AAA, is
probably related to the technique used in this study.
One bypass graft femoral anastomosis is performed
with a 7F angiogram catheter that passes through
the anastomosis, up the femoral artery, and into the
aortic graft so that a completion angiogram can be
performed. This procedure adds technical difficulty
to the anastomosis because there is the risk of a
suture being passed through the soft wall of the
catheter or around the catheter. In addition, angiog-
raphy is performed with all arterial clamps released;
there is a tendency for blood loss around the
catheter. We also have found that the Dacron bypass
graft is stiff and that completion of the anastomosis
may not provide a blood-tight seal on removal of the
angiogram catheter, which requires additional
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sutures to achieve hemostasis. This is further com-
plicated by the heparin (typically 5000 units) that is
given at the time of bypass graft deployment. The
passage of a 20F introducer sheath before deploy-
ment of the aortic component of the EVR may also
cause arterial damage at the anastomosis site. These
factors may have contributed to the high incidence
rate of postoperative hematomas in the groin. We
now have changed practice and use a PTFE bypass
graft, which is more pliable and makes the anasto-
mosis easier with an angiogram catheter in the
femoral artery. The only groin hematoma that has
occurred in the PTFE group was in the opposite
groin and was attributed to a technical difficulty of
the anastomosis in a calcified vessel. All of the groin
hematomas in the Dacron group occurred on the
side of the completion angiogram catheter.
The effect of an aortic uni-iliac graft on the flow
through a femorofemoral bypass graft has not yet
been fully investigated. After bypass graft deploy-
ment, intermittent claudication could develop in
patients who are asymptomatic. This problem has
been seen in some patients and may be related to
kinking or to the volume of an oversized bypass graft
within the iliac artery that causes a functional inflow
stenosis. This aspect needs further study.
Iliac limb occlusion may occur in up to 10% of
the patients treated with the currently available
bifurcated endovascular grafts.5,6 In the report by
Stelter et al,5 2 principal grafts were used—the
Stentor/Vanguard (Meadox/Boston Scientific
Corp, Oakland, NJ) and the Talent (World Medical
Manufacturing Corp, Sunrise, Fla). However, no
breakdown was given for the incidence rate of iliac
limb occlusion for the individual devices. In our own
series of 13 Chuter “home-made” bifurcated grafts,
1 iliac limb occlusion occurred at 3 months after
surgery. The incidence rate of femorofemoral bypass
graft occlusion after aorta uni-iliac EVR in the pre-
sented series is 1/136 (0.7%), and the incidence rate
of complications attributed to the femorofemoral
crossover bypass graft that required intervention is
4/136 (3%). Hematoma and superficial wound
infections may occur after an arteriotomy for arteri-
al access whether or not this is accompanied by a
femorofemoral crossover bypass graft; therefore, in
only 3/136 (2%) could a major complication be
attributed to the crossover bypass graft. This pro-
vides some support for the aorta uni-iliac graft
instead of the bifurcated graft, although the compli-
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Table I. Complications associated with femorofemoral crossover bypass grafts in 136 patients who under-
went endovascular repair of abdominal aortic aneurysms with aorta uni-iliac bypass grafts
No Complication Treatment Outcome Graft material Risk factors
1 Superficial wound infection Antibiotics Resolved Dacron
2 Superficial wound infection Antibiotics Resolved Dacron
3 Superficial wound infection Antibiotics Resolved Dacron
4 Wound infection and femoral Repair of femoral false Graft occlusion requiring Dacron
false aneurysm aneurysm revision
5 Superficial wound infection Antibiotics Resolved PTFE
6 Graft infection Graft removal and axillo No further complications Dacron
bifemoral bypass graft
7 Graft infection (MRSA) Infected graft removed Patient died of septicemia Dacron
and replaced with 
rifampicin-soaked graft
8 Groin hematoma Groin wound explored Patient died of dialysis line Dacron Anticoagulation
sepsis despite broad during hemo-
spectrum antibiotics dialysis
9 Groin hematoma Conservative Resolved Dacron Thrombocytopenia
10 Groin hematoma Conservative Resolved Dacron Patient underwent
warfarin therapy 
before surgery
11 Groin hematoma Conservative Resolved Dacron
12 Groin hematoma Conservative Resolved Dacron Thrombocytopenia
13 Groin hematoma Conservative Resolved Dacron Anticoagulation
14 Groin hematoma Groin exploration Resolved PTFE
15 Groin lymph leak Conservative Resolved Dacron
16 Groin lymphocele Surgically explored and Resolved PTFE
drained
16 Scrotal hematoma Conservative Resolved Dacron
17 Hematoma around graft Conservative Resolved Dacron
MRSA, methicillin-resistant Staphylococcus aureus; PTFE, polytetrafluoroethylene.
cation rate of iliac limb occlusion may be reduced
with further refinements of the bifurcated devices
currently available commercially. The refinement in
the selection criteria for both systems may also have
an impact on these complications.
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